CirrusDx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, today announced it now offers ...

The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...

Antimicrobial susceptibility testing (AST) is a fundamental component of modern clinical microbiology that informs therapeutic decisions and underpins surveillance of antimicrobial resistance. AST ...

A randomized clinical trial demonstrated the limits of rapid testing to determine the antibiotic susceptibility of ...

McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can stop them—in just 36 minutes, a major advance in the global effort to curb ...

In a multinational randomized trial, rapid antimicrobial susceptibility testing (AST) shortened the time to antibiotic modification in patients with gram-negative bacteremia but did not improve the ...

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility testing (AST) was not superior to usual testing in terms of clinical outcomes.

The company's rapid antimicrobial susceptibility testing platform can deliver results in under three hours, helping hospitals ...

In what represents the first patenting from Glasgow-based Microplate Dx Ltd., three of its co-founders describe a system for diagnosing microbial infections and performing rapid antimicrobial ...

Investigators at the Israel Institute for Biological Research have developed a rapid AST that can be performed directly on blood and environmental soil samples. 2,3 In a recent study, the ...